Article tools
Author information
Published in Volume 101, Issue 4 (February 15,1998)
J. Clin. Invest. 101(4): 827-833 (1998). doi:10.1172/JCI1722.
Copyright © 1998, The American Society for Clinical Investigation.

Research Article

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.

T Kikuchi, H W Yang, M Pennybacker, N Ichihara, M Mizutani, J L Van Hove and Y T Chen

Department of Animal Models for Human Disease, National Institute of Neuroscience, NCNP, Tokyo 187, Japan.

Published February 15, 1998

Pompe disease is a fatal genetic muscle disorder caused by a deficiency of acid alpha-glucosidase (GAA), a glycogen degrading lysosomal enzyme. GAA-deficient (AMD) Japanese quails exhibit progressive myopathy and cannot lift their wings, fly, or right themselves from the supine position (flip test). Six 4-wk-old acid maltase-deficient quails, with the clinical symptoms listed, were intravenously injected with 14 or 4.2 mg/kg of precursor form of recombinant human GAA or buffer alone every 2-3 d for 18 d (seven injections). On day 18, both high dose-treated birds (14 mg/kg) scored positive flip tests and flapped their wings, and one bird flew up more than 100 cm. GAA activity increased in most of the tissues examined. In heart and liver, glycogen levels dropped to normal and histopathology was normal. In pectoralis muscle, morphology was essentially normal, except for increased glycogen granules. In sharp contrast, sham-treated quail muscle had markedly increased glycogen granules, multi-vesicular autophagosomes, and inter- and intrafascicular fatty infiltrations. Low dose-treated birds (4.2 mg/kg) improved less biochemically and histopathologically than high dose birds, indicating a dose-dependent response. Additional experiment with intermediate doses and extended treatment (four birds, 5.7-9 mg/kg for 45 d) halted the progression of the disease. Our data is the first to show that an exogenous protein can target to muscle and produce muscle improvement. These data also suggest enzyme replacement with recombinant human GAA is a promising therapy for human Pompe disease.

This article Copyright © 1998, The American Society for Clinical Investigation.

Articles that cite
this article:

Neural deficits contribute to respiratory insufficiency in Pompe disease
L. R. Deruisseau, D. D. Fuller, K. Qiu, K. C. Deruisseau, W. H. Donnelly, C. Mah, P. J. Reier, B. J. Byrne
Proc Natl Acad Sci 106(23):9419. [CrossRef]

Establishment of Inbred Strains of Chicken and Japanese Quail and their Potential as Animal Models.
Makoto Mizutani
Exp Anim 51(5):417. [CrossRef]

Potential treatment of liver-related disorders with in vitro expanded human liver precursors
Ying Yang, Junke Zheng, Xiaofei Zhou, Zhuqin Yang, Yuedi Tan, Ailian Liu, Xiang Gao, Zai Chang, Hui Z. Sheng
The Journal of the International Society of Differentiation 0(0):070510020027001. [CrossRef]

Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe Mice
Robin J. Ziegler, Scott D. Bercury, Jonathan Fidler, Michael A. Zhao, Joseph Foley, Tatyana V. Taksir, Susan Ryan, Bradley L. Hodges, Ronald K. Scheule, Lamya S. Shihabuddin
Hum Gene Ther 19(6):609. [CrossRef]

Glycogen storage disease types I and II: Treatment updates
D. D. Koeberl, P. S. Kishnani, Y. T. Chen
J Inherit Metab Dis 30(2):159. [CrossRef]

Enzyme therapy for Pompe disease: from science to industrial enterprise
Arnold J. J. Reuser, Hannerieke Hout, Agnes G. A. Bijvoet, Marian A. Kroos, Martin P. Verbeet, Ans T. Ploeg
Eur J Pediatr 161(1):S106. [CrossRef]

A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth
S. Noori, R. Acherman, B. Siassi, C. Luna, M. Ebrahimi, Z. Pavlova, R. Ramanathan
J Perinat Med 30(6):517. [CrossRef]

Intercellular Transfer of the Virally Derived Precursor Form of Acid -Glucosidase Corrects the Enzyme Deficiency in Inherited Cardioskeletal Myopathy Pompe Disease
Daniel F. Pauly, Thomas J. Fraites, Catalin Toma, Helen S. Bayes, Maryann L. Huie, Rochelle Hirschhorn, Paul H. Plotz, Nina Raben, Paul D. Kessler, Barry J. Byrne
Hum Gene Ther 12(5):527. [CrossRef]

Long-Term Efficacy after [E1-, polymerase-] Adenovirus-Mediated Transfer of Human Acid--Glucosidase Gene into Glycogen Storage Disease Type II Knockout Mice
E.Y. Ding, B.L. Hodges, H. Hu, A.J. Mcvie-wylie, D. Serra, F.K. Migone, D. Pressley, Y.T. Chen, A. Amalfitano
Hum Gene Ther 12(8):955. [CrossRef]

Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy
Léon P. F. Winkel, Joep H. J. Kamphoven, Hannerieke J. M. P. Van den hout, Lies A. Severijnen, Pieter A. Van doorn, Arnold J. J. Reuser, Ans T. Van der ploeg
Muscle Nerve 27(6):743. [CrossRef]

News and views in Histochemistry and Cell Biology
Esther Asan, Detlev Drenckhahn
Histochemistry 122(6):593. [CrossRef]

Multiple muscles in the AMD quail can be “cross-corrected” of pathologic glycogen accumulation after intravenous injection of an [E1-, polymerase-] adenovirus vector encoding human acid-α-glucosidase
A. J. Mcvie-wylie, E. Y. Ding, T. Lawson, D. Serra, F. K. Migone, D. Pressley, M. Mizutani, T. Kikuchi, Y. T. Chen, A. Amalfitano
J Gene Med 5(5):399. [CrossRef]

Japanese quail (Coturnix japonica) as a laboratory animal model
David Huss, Greg Poynter, Rusty Lansford
Lab Anim 37(11):513. [CrossRef]

Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA
Fang Xu, Enyu Ding, Felicia Migone, Delila Serra, Ayn Schneider, Yuan-Tsong Chen, Andrea Amalfitano
J Gene Med 7(2):171. [CrossRef]

Glycogen storage diseases of muscle
Salvatore Dimauro, Claudio Bruno
Curr Opin Neurol [CrossRef]

Age-related decline in muscle strength and power output in acid 1-4 α-glucosidase knockout mice
Reinout P. Hesselink, Gerrit Van kranenburg, Anton J. M. Wagenmakers, Ger J. Van der vusse, Maarten R. Drost
Muscle Nerve 31(3):374. [CrossRef]

Differentiation of liver cells from human primordial germ cell-derived progenitors
Bin Chen, Jianjun Shi, Junke Zheng, Ying Chen, Kai Wang, Qingzhang Yang, Xuejin Chen, Zhuqing Yang, Xiaofei Zhou, Youming Zhu
The Journal of the International Society of Differentiation 75(5):350. [CrossRef]

Mutations of Japanese Quail (Coturnix japonica) and Recent Advances of Molecular Genetics for This Species
Masaoki Tsudzuki
J Poult Sci 45(3):159. [CrossRef]

Enzyme reconstitution/replacement therapy for lysosomal storage diseases
T Andrew Burrow, Robert J Hopkin, Nancy D Leslie, Bradley T Tinkle, Gregory A Grabowski
Curr Opin Pediatr 19(6):628. [CrossRef]

Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of α-glucosidase in Pompe disease
Gaëlle Douillard-guilloux, Emmanuel Richard, Lionel Batista, Catherine Caillaud
J Gene Med 11(4):279. [CrossRef]